|
People
The highly qualified and motivated team at ESBATech and the entrepreneurial spirit encourage a creative and innovative culture, dedicated to develop ideas and find solutions that help to fulfil the partner's need and Company goals.
The Company has currently about 40 employees. The majority hold an MD, PhD or a Master of Science degree in the fields of Molecular Biology, Biochemistry, Immunology or Medicine.
ESBATech is backed by an outstanding panel of investors, a highly experienced board of directors and an excelling scientific advisory board.
Senior Management
|
|
Dominik Escher, Ph.D. | Chief Executive Officer | >> CV
|
| Martin Gertsch, CPA | Chief Financial Officer | >> CV
|
| James J. Egan, J.D. | Chief Business Officer | >> CV
|
| Anne Schmidt, Ph.D. | Head Project Management |
|
| David Urech, Ph.D. | Head Research & Development | >> CV
|
| Peter Lichtlen, MD/Ph.D. | Head Clinical Development | >> CV
|
| Peter Steiner, Ph.D. | Head Production & Processes | >> CV
|
Management
|
|
Esther Furrer, Ph.D. | Senior Scientist, Head in vivo Biology |
|
| Ilknur Lechthaler | Head Clinical Operations |
|
| Markus Jauslin | Accounting/Controlling |
|
| Oliver Middendorp, Ph.D. | Head Alliance Management | >> CV
|
| Tea Gunde, Ph.D. | Senior Scientist, Head Molecular Biology/Assay Development | >> CV
|
Board of Directors
|
|
Thomas Hecht, MD | Chairman of the Board of Directors of ESBATech AG.
Former VP Marketing, former Director Medical Affairs Amgen Europe
|
| Graham Boulnois, Ph.D. | Partner of SV Life Sciences.
Former positions included Senior Vice President R&D, Aventis Pharma,
Global Vice President Enabling Technologies, Astra Zeneca,
Senior Vice President Discovery, Zeneca, and Professor and
Chairman of Biological Sciences at Leicester University
|
| Dominik Escher, Ph.D. | Delegate of the Board of Directors of ESBATech AG,
CEO ESBATech AG
|
| Chandra P. Leo, MD, MBA | Investment Advisor
of HBM Partners.
Former positions include Principle at Wellington Partners and physician/scientist at University Hospital Leipzig and Stanford University. |
| Arnd Kaltofen, MD | Partner VI Partners AG
|
| Gerhard Ries, Ph.D. | Co-founder and Managing Partner of BioMedinvest and
strong background in the pharmaceutical, biotechnology and consulting
industry.
Former positions included executive management positions at Novartis,
McKinsey and PharmaInterLink and R&D positions at Ciba-Geigy, Boehringer
Mannheim, Harvard Medical School and the Max-Planck-Institute for
Biochemistry
|
| Michael Steinmetz, Ph.D. | Managing Director of Clarus Ventures.
Former positions included Vice President of Preclinical Research and Development
and Global Head of Biotechnology at Hoffmann-La Roche
|
Secretary of the Board of Directors
|
|
Adrian Escher | Deputy CEO Kendris Private AG
|
|
|
|
